Five chief medical officers from leading medical marketing agencies weigh in on how the job has changed and where it’s going.

Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement ...